Fundamental Analysis
MAX INDIA LTD.
{Ticker : 539981 { BUY: Rs. 92.10 { Target: Rs.104
Max India is engaged in the business of investments and providing consultancy services to group companies. The company, through its subsidiaries, offers health insurance, healthcare and senior living services. On a consolidated quarterly front, the net sales of the company saw a drop of nearly two per cent in Q3FY20 to Rs 33.92 crore from Rs 34.6 crore in Q3FY19. The company incurred an operating loss of Rs 50.04 crore in Q3FY20 as compared to an operating loss of Rs 17.91 crore in Q3FY19. Largely through income from discontinued operations, the company reported a net profit of Rs 366.68 crore in Q3FY20 as against a net loss of Rs 30.31 crore in Q3FY19. With its recent divestment from Max Bupa, the company is rebalancing its portfolio of businesses with a sharp focus of growing shareholder value. We thus, recommend a BUY.